Your browser doesn't support javascript.
loading
Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.
Marateb, Hamid Reza; von Cube, Maja; Sami, Ramin; Haghjooy Javanmard, Shaghayegh; Mansourian, Marjan; Amra, Babak; Soltaninejad, Forogh; Mortazavi, Mojgan; Adibi, Peyman; Khademi, Nilufar; Sadat Hosseini, Nastaran; Toghyani, Arash; Hassannejad, Razieh; Mañanas, Miquel Angel; Binder, Harald; Wolkewitz, Martin.
Afiliação
  • Marateb HR; Biomedical Engineering Department, Engineering Faculty, University of Isfahan, Isfahan, Iran. h.marateb@eng.ui.ac.ir.
  • von Cube M; Biomedical Engineering Research Centre (CREB), Automatic Control Department (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC)Building H, Floor 4, Av. Diagonal 647, 08028, Barcelona, Spain. h.marateb@eng.ui.ac.ir.
  • Sami R; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
  • Haghjooy Javanmard S; Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Mansourian M; Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Amra B; Biomedical Engineering Research Centre (CREB), Automatic Control Department (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC)Building H, Floor 4, Av. Diagonal 647, 08028, Barcelona, Spain. marjan.mansourian@upc.edu.
  • Soltaninejad F; Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran. marjan.mansourian@upc.edu.
  • Mortazavi M; Bamdad Respiratory Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Adibi P; The Respiratory Research Center, Pulmonary Division, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Khademi N; Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Sadat Hosseini N; Isfahan Gastroenterology and Hepatology Research Center (lGHRC), Isfahan University of Medical Sciences, Isfahan, Iran.
  • Toghyani A; School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Hassannejad R; School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Mañanas MA; School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Binder H; Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Wolkewitz M; Biomedical Engineering Research Centre (CREB), Automatic Control Department (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC)Building H, Floor 4, Av. Diagonal 647, 08028, Barcelona, Spain.
BMC Med Res Methodol ; 21(1): 146, 2021 07 14.
Article em En | MEDLINE | ID: mdl-34261439
ABSTRACT

BACKGROUND:

Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis.

METHODS:

We used the hospital-based open Khorshid COVID Cohort (KCC) study with 630 COVID-19 patients from Isfahan, Iran. Competing risk methods are used to develop a death risk chart based on the following variables, which can simply be measured at hospital admission sex, age, hypertension, oxygen saturation, and Charlson Comorbidity Index. The area under the receiver operator curve was used to assess accuracy concerning discrimination between patients discharged alive and dead.

RESULTS:

Cause-specific hazard regression models show that these baseline variables are associated with both death, and discharge hazards. The risk chart reflects the combined results of the two cause-specific hazard regression models. The proposed risk assessment method had a very good accuracy (AUC = 0.872 [CI 95% 0.835-0.910]).

CONCLUSIONS:

This study aims to improve and validate a personalized mortality risk calculator based on hospitalized COVID-19 patients. The risk assessment of patient mortality provides physicians with additional guidance for making tough decisions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article